Moreover, it has been reported that the status of a single gene (e.g., estrogen receptor (ER)) can distinguish the bone-metastasis risk in breast cancer [50], so we also compared the performance of ER status and our method in evaluating the risk of bone metastasis of breast cancer. The gene discussed is ESR1; the disease is breast carcinoma.